| Literature DB >> 34129223 |
Jennifer S Peel1, Melitta A McNarry2, Shane M Heffernan2, Venturino R Nevola2,3, Liam P Kilduff2,4, Mark Waldron2,4,5.
Abstract
BACKGROUND: The ergogenic effects of dietary supplements on endurance exercise performance are well-established; however, their efficacy in hot environmental conditions has not been systematically evaluated.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34129223 PMCID: PMC8514372 DOI: 10.1007/s40279-021-01500-2
Source DB: PubMed Journal: Sports Med ISSN: 0112-1642 Impact factor: 11.136
Fig. 1Process of study selection
Summary of studies included in the meta-analyses (n = 25)
| Study | Design | Sample | Supplement, dose and timing | Temperature and relative humidity | Core temperature method | Exercise performance type | Outcome |
|---|---|---|---|---|---|---|---|
| Beaumont et al. [ | Double-blind, randomised, repeated measures, cross-over | Healthy, recreationally active, non-heat acclimated males ( | Caffeine 6 mg·kg−1 (60 min pre-exercise) | 30 °C 50% RH | Gastrointestinal every 5 min (ECT + SCT) | 60 min cycling @ 55% | NS ~ 3% ↑ in TT performance |
| Cheuvront et al. [ | Double-blind, randomised, cross-over | Healthy, physically active, moderately fit, non-heat acclimated males ( | Caffeine 9 mg·kg−1 (timing not mentioned) | 40 °C 20–30% RH | Rectal every 5 min (ECT + SCT) | 30 min cycling @ 50% | NS ~ 2.4% ↑ in TT performance |
| Ferreira et al. [ | Double-blind, randomised, cross-over | Well-trained, heat acclimated, male cyclists ( | Caffeine 5 mg·kg−1 (60 min pre-exercise) | 30 °C average, ranged from 28.5–32 °C 71–78% RH | Tympanic pre and post exercise (ECT) | 45 km cycling TT | NS ~ 4.2% ↑ in TT performance |
| Ganio et al. [ | Double-blind, randomised, cross-over | Healthy, trained, non-heat acclimated male cyclists ( | Caffeine 3 mg·kg−1 (60 min pre-exercise) | 33 °C 41% RH | Rectal every 15 min (ECT + SCT) | 90 min cycling @ 65% thermoneutral | NS ~ 6.3% ↑ in TT performance |
| Hanson et al. [ | Single-blind, randomised, cross-over | Trained male ( | Caffeine 6 mg·kg−1 (60 min pre-exercise) | 30.6 °C 50% RH | Gastrointestinal every 1 km (ECT + SCT) | 10 km running TT | NS ~ 0.9% ↑ in TT performance |
| Ping et al. [ | Double-blind, randomised, cross-over | Recreational, heat acclimated male runners ( | Caffeine 5 mg·kg−1 (60 min pre-exercise) | 31 °C 70% RH | Rectal every 10 min (ECT) | Treadmill running @ 70% | Significant ~ 27.4% ↑ in TTE |
| Pitchford et al. [ | Double-blind, randomised, counterbalanced, cross-over | Highly-trained, non-heat acclimated male cyclists ( | Caffeine 3 mg·kg−1 (90 min pre-exercise) | 35 °C 25% RH | Gastrointestinal continuously (ECT + SCT) | Total work cycling TT | NS ~ 6.9% ↑ in TT performance |
| Roelands et al. [ | Double-blind, randomised, cross-over | Healthy, trained, non-heat acclimated males ( | Caffeine 6 mg·kg−1 (60 min pre-exercise) | 30 °C 50–60% RH | Rectal every 5 min (ECT + SCT) | 60 min cycling @ 55% | NS ~ 3% ↓ in TT performance |
| Suvi et al. [ | Double-blind, randomised, cross-over | Healthy, physically active, non-heat acclimated males ( | Caffeine 6 mg·kg−1 (4 mg·kg−1 60 min and 2 mg·kg−1 0 min pre-exercise) | 42 °C 20% RH | Measured but no extractable data | 50 min treadmill walking @ 60% thermoneutral | NS ~ 4.3% ↓ in TTE |
| Kilduff et al. [ | Double-blind, randomised, independent design | Endurance-trained, non-heat acclimated males ( | Creatine 159.6 g (7 × 22.8 g·day−1) | 30.3 °C 70% RH | Rectal every 5 min (ECT + SCT) | Cycling @ incremental work rate at 60–90 rpm | NS ~ 3% ↓ in TTE |
| Fowler et al. [ | Double-blind, randomised, cross-over | Healthy, physically inactive, non-heat acclimated males ( | Nitrate (NO3−) 46 mmol (5 × 9.2 mmol·day−1) | 35 °C 28% RH | Rectal every 1 min (ECT + SCT) | Cycling @ thermoneutral gas exchange threshold at 70 rpm | NS ~ 9.7% ↑ in TTE |
| Kent et al. [ | Double-blind, repeated measures, counter-balanced, cross-over | Endurance-trained male cyclists ( | Nitrate (NO3−) 26 mmol (2 × 6.5 mmol·day−1 and 13 mmol 2 h pre-exercise) | 35 °C 48% RH | Gastrointestinal every 20% work rate (ECT + SCT) | Total work cycling TT | NS ~ 3.1% ↑ in TT performance |
| McQuillan et al. [ | Double-blind, randomised, cross-over | Healthy, well-trained endurance male cyclists ( | Nitrate (NO3−) 24 mmol (2 × 8 mmol·d−1 and 8 mmol 90 min pre-exercise) | 35 °C 60% RH | Rectal continuously (ECT + SCT) | 20 min cycling @ 40–60% PPO followed by 4 km TT | NS ~ 0.3% ↑ in TT performance |
| Smith et al. [ | Double-blind, randomised, counterbalanced, cross-over | Recreationally-trained males ( | Nitrate (NO3−) 6.2 mmol (3 h pre-exercise) | 30 °C 70% RH | Tympanic post IST (ECT) | 20 × 6 s sprints (114 s active recovery) | NS ~ 1.5% ↓ in mean power output |
| Cheuvront et al. [ | Cross-over | Healthy, physically active, moderately fit, heat acclimated males ( | BCAAs 14 g·kg−1 (0 min pre- and during exercise) | 40 °C 20% RH | Rectal every 10 min (ECT + SCT) | 60 min cycling @ 50% | NS ~ 14.3% ↑ in TT performance |
| Mittleman et al. [ | Double-blind, cross-over | Healthy, moderately-trained males ( | BCAAs Females (9.4 g) and males (15.8 g; 5 mL·kg−1 of 5.88 g·L−1 (Every 60 min at rest and 30 min during exercise) | 34.4 °C 39% RH | Oesophageal every 5 min (ECT + SCT) | Cycling @ 40% | Significant ~ 11.1% ↑ in TTE |
| Watson et al. [ | Double-blind, randomised, cross-over | Healthy, endurance exercising, non-heat acclimated males ( | BCAAs 4 × 250 ml at 12 g·L−1 (30 min intervals pre-exercise and 150 ml every 15 min during exercise) | 30 °C 38% RH | Rectal every 10 min (ECT + SCT) | Cycling @ 50% | NS ~ 6.6% ↑ in TTE |
| Coull et al. [ | Double-blind, counter-balanced, cross-over | Recreationally active, non-heat acclimated males ( | Tyrosine 150 mg·kg−1 (60 min pre-exercise) | 40 °C 30% RH | Rectal every 5 min (ECT + SCT) | 60 min treadmill walk followed by 2.4 km TT wearing a 25 kg backpack | NS ~ 5% ↑ in TT performance |
| Tumilty et al. [ | Double-blind, randomised, cross-over | Healthy, endurance exercising, non-heat acclimated males ( | Tyrosine 150 mg·kg−1 (60 pre-exercise) | 30 °C 60% RH | Rectal every 10 min (ECT + SCT) | Cycling @ 68% | Significant ~ 14.8% ↑ in TTE |
| Tumilty et al. [ | Double-blind, randomised, cross-over | Endurance exercising, non-heat acclimated males ( | Tyrosine 150 mg·kg−1 (60 pre-exercise) | 30 °C 60% RH | Rectal every 5 min (ECT + SCT) | 60 min cycling @ 57% | NS ~ 1.1% ↑ in TT performance |
| Watson et al. [ | Randomised, counter-balanced, cross-over | Physically active, trained, non-heat acclimated males ( | Tyrosine 150 mg·kg−1 (2 h, 1 h, and during) | 30 °C 50% RH | Rectal every 5 min (ECT + SCT) | Cycling @ 70% | NS ~ 2% ↓ in TTE |
| Keong et al. [ | Double-blind, randomised, cross-over | Recreational, heat acclimated male athletes ( | Vitamin E No dose stated (6 week pre-exercise) | 31 °C 70% RH | Rectal every 10 min (ECT + SCT) | Treadmill running @ 70% | NS ~ 5.3% ↑ in TTE |
| Muhamad et al. [ | Double-blind, randomised, cross-over | Healthy, male recreational athletes ( | E. longifolia Jack 1200 mg (7 × 150 mg·d−1 and 150 mg 60 min pre-exercise) | 31 °C 70% RH | Tympanic every 10 min (ECT) | 60 min treadmill running @ 60% | NS ~ 3.6% ↑ in TT performance |
| Page et al. [ | Double-blind, randomised, cross-over | Healthy, non-heat acclimated males ( | Taurine 50 mg·kg−1 (2 h pre-exercise) | 35 °C 40% RH | Rectal every 1 min (ECT + SCT) | Cycling @ thermoneutral ventilatory threshold at 80 rpm | Significant ~ 11.5% ↑ in TTE |
| Trinity et al. [ | Double-blind, randomised, cross-over | Healthy, well-trained male cyclists ( | Polyphenols 25,200 ppm (7 × 3600-ppm·day−1) | 31.5 °C 55% RH | Rectal continuously (ECT + SCT) | 10 min cycling @ 60–70% | NS ~ 3.5% ↓ in TTE |
TT time-trial, TTE time-to-exhaustion, IST intermittent sprint test, NS non-significant, PPO peak power output, Wmax maximal workload, ECT end core temperature, SCT submaximal core temperature, RH relative humidity, maximal oxygen uptake, peak oxygen uptake, BCAAs branched-chain amino acids
aNot included in submaximal core temperature analysis
bNot included in end core temperature analysis. The table is a reflection of participant characteristics, as reported by the authors of the articles
Fig. 2Effect of dietary supplementation on exercise performance
Fig. 3Effect of dietary supplementation on a end core temperature and b submaximal core temperature
Fig. 4Effect of dietary supplementation on exercise performance by exercise modality
Fig. 5Effect of dietary supplementation on a end core temperature and b submaximal core temperature by exercise modality
Meta-regression outcomes
| Moderator | Exercise performance | End core temperature response | Submaximal core temperature response |
|---|---|---|---|
| Training status | |||
| Heat acclimation status | |||
| Hydration status | |||
| Fluid ingestion during exercise | |||
| Fed vs fasted state | |||
| Acute heat exposure beforehand | |||
| Exercise beforehand | |||
| Duration of performance protocol | |||
| Total duration of exercise |
Fig. 6Risk of bias
Fig. 7Publication bias for a exercise performance, b end core temperature and c submaximal core temperature
| Exercising in the heat appears to affect the efficacy of many dietary supplements, suggesting that findings from research conducted on certain supplements in thermoneutral conditions are not necessarily transferrable to other environmental conditions. |
| Certain supplements, such as caffeine and nitrate, lack sufficient data to support their use as ergogenic aids in the heat, despite their efficacy in thermoneutral conditions, with caffeine also increasing core temperature responses. Some amino acids might offer the greatest performance benefits in the heat. |
| A potential risk is posed to those in physical performance domains (i.e., athletes or military personnel) due to the limited guidance on how to supplement appropriately for endurance exercise in hot environments. |